StonvexLoading…
StonvexStonvexStonvexCore line items from MYGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $200.40M | $824.50M | $614.70M | $409.00M |
Operating Income | $-30.70M | $-387.20M | $-381.50M | $-358.20M |
Net Income | $-34.10M | $-365.90M | $-358.00M | $-330.50M |
EPS (Diluted) | $-0.36 | $-3.95 | $-3.88 | $-3.59 |
Total Assets | $673.70M | $706.60M | $728.10M | $677.30M |
Total Liabilities | $336.30M | $338.60M | $355.30M | $289.20M |
Cash & Equivalents | $124.40M | $149.60M | $145.40M | $74.40M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 94.40M | 93.50M | 93.10M | 93.10M |